Article
Generation of induced pluripotent stem cell line (IGIBi007-A) from a patient with a novel acromesomelic dysplasia, PRKG2 type (AMDP).
Stem cell research - 1 May 2021
Kumar Manish, Wadhwa Saruchi, Tyagi Nishu, Ahmad Istaq, Kumar Somesh, Sagar Shakti, Zahra Sana, Kamai Asangla, Shamim Uzma, Kapoor Seema, Faruq Mohammed
Abstract excerpt
Biallelic PRKG2 (Protein Kinase, cGMP dependent Type-2) mutations cause a novel acromesomelic dysplasia PRKG2 type. We report generation of induced pluripotent stem cell line from lymphoblastoid cell lines of the patient carrying the reported frameshift mutation (p.Asn164Lysfs*2). The derived iPSC line exhibits all the features of pluripotency, free of major genetic alterations due to reprogramming process and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
